植物大对急性支气管炎咳严重性的影响:一项双盲随机临床试验
Alireza Naderi1, Seyyed Ali Mozaffarpur2, Hoda Shirafkan3
1Student Research Center, Babol University of Medical Sciences, Babol, Iran.
Caspian journal of internal medicine
|October 3, 2024
概括
植物大糖 (PMS) 有效地减少咳的严重程度,并改善了急性支气管炎患者的生活质量. 这种天然疗法提供了息治疗,显著缓解了症状,没有任何不良影响.
科学领域:
- 草药研究 草药研究
- 呼吸系统药物 呼吸系统药物
- 临床药理学 临床药理学
背景情况:
- 急性支气管炎的管理通常包括支持性护理以缓解症状.
- 对于治疗急性支气管炎症状的自然疗法,证据有限.
研究的目的:
- 评估Plantago主要糖 (PMS) 在缓解急性支气管炎患者咳严重性的疗效.
- 评估PMS对急性支气管炎患者生活质量的影响.
主要方法:
- 一个随机的,安慰剂对照试验与80名被诊断患有急性支气管炎的成年患者进行.
- 患者每天接受30毫升的Plantago大糖或安慰剂10天.
- 咳的严重程度使用支气管炎严重程度量表 (BSS) 进行测量,使用波斯莱斯特咳问卷 (LCQ) 评估生活质量.
主要成果:
- 与安慰剂相比,Plantago主要糖显著降低了支气管炎严重程度等级分数 (P=0.001).
- 关键症状,如咳频率,唾液产量和胸痛在PMS组明显较低.
- 在所有领域 (心理,身体,社会) 和在PMS组中莱斯特咳问卷的总得分中观察到显著的改善.
结论:
- 普兰塔戈大糖在治疗急性支气管炎症状方面表现出缓解作用.
- 治疗PMS导致患有急性支气管炎的患者的生活质量显著改善.
- 这项研究在这个患者队列中没有发现与Plantago大糖使用相关的显著不良影响.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
185
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
185
01:20COPD: Pathogenesis and Clinical Features
242
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
242
01:24Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
01:20Asthma: Pathogenesis and Management
363
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
363
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K